37109811000001106: Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)
\UK product\Virtual medicinal product\Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment\Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)
\UK product\Virtual therapeutic moiety\Calcipotriol + Betamethasone\Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment\Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)

\Medicinal product\Product containing vitamin (product)\Product containing fat-soluble vitamin (product)\Product containing vitamin D and/or vitamin D derivative (product)\Product containing calcipotriol\Product containing betamethasone and calcipotriol\Calcipotriol + Betamethasone\Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment\Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing betamethasone\Product containing betamethasone and calcipotriol\Calcipotriol + Betamethasone\Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment\Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing betamethasone\Product containing betamethasone and calcipotriol\Calcipotriol + Betamethasone\Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment\Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing fluorinated corticosteroid\Product containing betamethasone\Product containing betamethasone and calcipotriol\Calcipotriol + Betamethasone\Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment\Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing glucocorticoid\Product containing betamethasone\Product containing betamethasone and calcipotriol\Calcipotriol + Betamethasone\Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment\Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing vitamin D and/or vitamin D derivative (product)\Product containing calcipotriol\Product containing betamethasone and calcipotriol\Calcipotriol + Betamethasone\Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment\Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

159841000001115 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

159851000001117 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Is a	Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Betamethasone	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Calcipotriol	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Has dispensed dose form	Ointment	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	VMP non-availability indicator	Re-introduced	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Has specific active ingredient	Calcipotriol hydrate	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Has specific active ingredient	Betamethasone dipropionate	true	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals) 120 gram	Has AMP	True	Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals) 60 gram	Has AMP	True	Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Inferred relationship	Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals) 30 gram	Has AMP	True	Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
159841000001115	Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
159851000001117	Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module